Core B: Developmental Core Staff of the core will include Core Director John M. Coffin, Ph.D. He is Professor of Molecular Biology and Microbiology, Tufts University School of Medicine. Dr. Coffin is a leading figure in research on the biology of retroviruses. Dr. Coffin's responsibilities will be to oversee the process of soliciting, reviewing and awarding developmental funding, and to initiate a program to encourage the recruitment and development of minority scientists. Basic purposes of the core will be 1) to provide developmental awards through a peer-reviewed process in order to encourage new research and to attract new investigators to the HIV/AIDS research field; 3) to expand the number of investigators from under-represented minority groups who are active in the field of AIDS research. Developmental Funds will be earmarked to three types of projects: pilot projects involving established AIDS investigators who desire to develop data regarding a hypothesis that may result in a full RO1 submission; Initial AIDS research projects that involve investigators new the AIDS research fielding initiating an HIV/AIDS research; and collaborative projects that allow two or more established investigators to form a creative collaboration that will produce synergy between the research being performed in different disciplines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042853-03
Application #
6338625
Study Section
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
3
Fiscal Year
2000
Total Cost
$92,908
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
039318308
City
Providence
State
RI
Country
United States
Zip Code
02906
Stone, Andrew C; Carroll, Jennifer J; Rich, Josiah D et al. (2018) Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months. Drug Alcohol Depend 192:94-97
Chan, Philip A; Montgomery, Madeline C; Rose, Jennifer et al. (2018) Statewide Evaluation of New HIV Diagnoses in Rhode Island: Implications for Prevention. Public Health Rep 133:489-496
Akiyama, Hisashi; Miller, Caitlin M; Ettinger, Chelsea R et al. (2018) HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction. Nat Commun 9:3450
Dong, Kimberly R; Must, Aviva; Tang, Alice M et al. (2018) Food Insecurity, Morbidities, and Substance Use in Adults on Probation in Rhode Island. J Urban Health 95:564-575
Skeer, Margie R; Ladin, Keren; Wilkins, Lindsay E et al. (2018) 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs. Drug Alcohol Depend 190:246-254
Ma, Y; Horsburgh, C R; White, L F et al. (2018) Quantifying TB transmission: a systematic review of reproduction number and serial interval estimates for tuberculosis. Epidemiol Infect 146:1478-1494
Wurcel, Alysse G; Burke, Deirdre; Skeer, Margie et al. (2018) Sex work, injection drug use, and abscesses: Associations in women, but not men. Drug Alcohol Depend 185:293-297
Dompreh, Albert; Tang, Xiaoli; Zhou, Jianlin et al. (2018) Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis. Antimicrob Agents Chemother 62:
Schackman, Bruce R; Gutkind, Sarah; Morgan, Jake R et al. (2018) Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug Alcohol Depend 185:411-420
Adams, Joƫlla W; Bryant, Kendall J; Edelman, Jennifer E et al. (2018) Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men. AIDS Behav 22:1341-1351

Showing the most recent 10 out of 806 publications